Skip to main content

Crizanlizumab



General

Pronunciation

(KRIZ an LIZ ue mab)

Indications

Use: Labeled Indications

Sickle cell disease: To reduce the frequency of vaso-occlusive crises in adults and pediatric patients ≥16 years of age with...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×